JOHNSON & JOHNSON (JNJ) Retained Earnings (Accumulated Deficit) USD 2009 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Johnson & Johnson quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2009 to 2024.
  • Johnson & Johnson Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was $153B, a 23.1% increase year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $153B +$28.8B +23.1% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $154B +$25.5B +19.9% Dec 31, 2023 10-Q 2024-05-01
Q3 2023 $153B +$24.6B +19.2% Oct 1, 2023 10-Q 2023-10-27
Q2 2023 $129B +$3.17B +2.51% Jul 2, 2023 10-Q 2023-07-31
Q1 2023 $125B +$178M +0.14% Apr 2, 2023 10-Q 2023-04-28
Q4 2022 $128B +$5.29B +4.3% Jan 1, 2023 10-K 2024-02-16
Q3 2022 $128B +$6.83B +5.64% Oct 2, 2022 10-Q 2022-10-27
Q2 2022 $126B +$6.06B +5.05% Jul 3, 2022 10-Q 2022-07-29
Q1 2022 $124B +$7.87B +6.76% Apr 3, 2022 10-Q 2022-04-29
Q4 2021 $123B +$9.17B +8.05% Jan 2, 2022 10-K 2023-02-16
Q3 2021 $121B +$6.26B +5.45% Oct 3, 2021 10-Q 2021-10-29
Q2 2021 $120B +$6.26B +5.49% Jul 4, 2021 10-Q 2021-07-29
Q1 2021 $117B +$3.61B +3.2% Apr 4, 2021 10-Q 2021-04-30
Q4 2020 $114B +$3.23B +2.92% Jan 3, 2021 10-K 2022-02-17
Q3 2020 $115B +$5.59B +5.12% Sep 27, 2020 10-Q 2020-10-23
Q2 2020 $114B +$4.09B +3.72% Jun 28, 2020 10-Q 2020-07-24
Q1 2020 $113B +$6.25B +5.86% Mar 29, 2020 10-Q 2020-04-29
Q4 2019 $111B +$4.44B +4.18% Dec 29, 2019 10-K 2021-02-22
Q3 2019 $109B +$1.63B +1.51% Sep 29, 2019 10-Q 2019-10-28
Q2 2019 $110B +$3.69B +3.47% Jun 30, 2019 10-Q 2019-07-29
Q1 2019 $107B +$2.31B +2.22% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $106B +$4.42B +4.35% Dec 30, 2018 10-K 2020-02-18
Q3 2018 $108B -$7.19B -6.26% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $106B -$7.09B -6.26% Jul 1, 2018 10-Q 2018-08-02
Q1 2018 $104B -$7.3B -6.54% Apr 1, 2018 10-Q 2018-05-01
Q4 2017 $102B -$8.76B -7.92% Dec 31, 2017 10-K 2019-02-20
Q3 2017 $115B +$5.95B +5.46% Oct 1, 2017 10-Q 2017-11-02
Q2 2017 $113B +$6.47B +6.06% Jul 2, 2017 10-Q 2017-08-03
Q1 2017 $112B +$6.65B +6.34% Apr 2, 2017 10-Q 2017-05-08
Q4 2016 $111B +$6.67B +6.42% Jan 1, 2017 10-K 2018-02-21
Q3 2016 $109B +$6.11B +5.95% Oct 2, 2016 10-Q 2016-11-04
Q2 2016 $107B +$5.39B +5.31% Jul 3, 2016 10-Q 2016-08-04
Q1 2016 $105B +$6.33B +6.42% Apr 3, 2016 10-Q 2016-05-10
Q4 2015 $104B +$6.63B +6.82% Jan 3, 2016 10-K 2017-02-27
Q3 2015 $103B +$6.19B +6.41% Sep 27, 2015 10-Q 2015-10-30
Q2 2015 $101B +$7.61B +8.12% Jun 28, 2015 10-Q 2015-07-31
Q1 2015 $98.7B +$7.27B +7.95% Mar 29, 2015 10-Q 2015-05-01
Q4 2014 $97.2B +$7.75B +8.66% Dec 28, 2014 10-K 2016-02-24
Q3 2014 $96.6B +$8.86B +10.1% Sep 28, 2014 10-Q 2014-10-30
Q2 2014 $93.7B +$4.3B +4.8% Jun 29, 2014 10-Q 2014-08-01
Q1 2014 $91.4B +$4.15B +4.75% Mar 30, 2014 10-Q 2014-05-02
Q4 2013 $89.5B +$3.5B +4.07% Dec 29, 2013 10-K 2015-02-24
Q3 2013 $87.7B +$2.82B +3.33% Sep 29, 2013 10-Q 2013-11-04
Q2 2013 $89.4B +$5.92B +7.09% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 $87.2B +$4.14B +4.98% Mar 31, 2013 10-Q 2013-05-03
Q4 2012 $86B +$4.74B +5.84% Dec 30, 2012 10-K 2014-02-21
Q3 2012 $84.9B +$2.25B +2.72% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $83.5B +$2.69B +3.33% Jul 1, 2012 10-Q 2012-08-02
Q1 2012 $83.1B +$3.59B +4.51% Apr 1, 2012 10-Q 2012-05-07
Q4 2011 $81.3B +$3.48B +4.47% Jan 1, 2012 10-K 2013-02-22
Q3 2011 $82.6B +$5.36B +6.94% Oct 2, 2011 10-Q 2011-11-08
Q2 2011 $80.8B +$5.58B +7.42% Jul 3, 2011 10-Q 2011-08-09
Q1 2011 $79.5B +$6.33B +8.65% Apr 3, 2011 10-Q 2011-05-10
Q4 2010 $77.8B +$7.47B +10.6% Jan 2, 2011 10-K 2012-02-23
Q3 2010 $77.3B Oct 3, 2010 10-Q 2010-11-10
Q2 2010 $75.3B Jul 4, 2010 10-Q 2010-08-11
Q1 2010 $73.2B Apr 4, 2010 10-Q 2010-05-10
Q4 2009 $70.3B Jan 3, 2010 10-K 2011-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.